Literature DB >> 31597715

Anti-donor MHC Class II Alloantibody Induces Glomerular Injury in Mouse Renal Allografts Subjected to Prolonged Cold Ischemia.

Victoria Gorbacheva1, Ran Fan1, Ashley Beavers1, Robert L Fairchild1, William M Baldwin1, Anna Valujskikh2.   

Abstract

BACKGROUND: The mechanisms underlying the effects of prolonged cold-ischemia storage on kidney allografts are poorly understood.
METHODS: To investigate effects of cold ischemia on donor-reactive immune responses and graft pathology, we used a mouse kidney transplantation model that subjected MHC-mismatched BALB/c kidney allografts to cold-ischemia storage for 0.5 or 6 hours before transplant into C57BL/6 mice.
RESULTS: At day 14 post-transplant, recipients of allografts subjected to 6 versus 0.5 hours of cold-ischemia storage had increased levels of anti-MHC class II (but not class I) donor-specific antibodies, increased donor-reactive T cells, and a significantly higher proportion of transplant glomeruli infiltrated with macrophages. By day 60 post-transplant, allografts with a 6 hour cold-ischemia time developed extensive glomerular injury compared with moderate pathology in allografts with 0.5 hour of cold-ischemia time. Pathology was associated with increased serum levels of anti-class 2 but not anti-class 1 donor-specific antibodies. Recipient B cell depletion abrogated early macrophage recruitment, suggesting augmented donor-specific antibodies, rather than T cells, increase glomerular pathology after prolonged cold ischemia. Lymphocyte sequestration with sphingosine-1-phosphate receptor 1 antagonist FTY720 specifically inhibited anti-MHC class II antibody production and abrogated macrophage infiltration into glomeruli. Adoptive transfer of sera containing anti-donor MHC class II antibodies or mAbs against donor MHC class II restored early glomerular macrophage infiltration in FTY720-treated recipients.
CONCLUSIONS: Post-transplant inflammation augments generation of donor-specific antibodies against MHC class II antigens. Resulting MHC class II-reactive donor-specific antibodies are essential mediators of kidney allograft glomerular injury caused by prolonged cold ischemia.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  glomerulopathy; immunology and pathology; ischemia; transplantation

Mesh:

Substances:

Year:  2019        PMID: 31597715      PMCID: PMC6900787          DOI: 10.1681/ASN.2018111169

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  53 in total

1.  Delayed graft function: risk factors and implications for renal allograft survival.

Authors:  A O Ojo; R A Wolfe; P J Held; F K Port; R L Schmouder
Journal:  Transplantation       Date:  1997-04-15       Impact factor: 4.939

2.  The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients.

Authors:  A Sicard; T W Phares; H Yu; R Fan; W M Baldwin; R L Fairchild; A Valujskikh
Journal:  Am J Transplant       Date:  2012-03-15       Impact factor: 8.086

3.  Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.

Authors:  C Wiebe; I W Gibson; T D Blydt-Hansen; M Karpinski; J Ho; L J Storsley; A Goldberg; P E Birk; D N Rush; P W Nickerson
Journal:  Am J Transplant       Date:  2012-03-19       Impact factor: 8.086

4.  Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants.

Authors:  A M K Kaul; S Goparaju; N Dvorina; S Iida; K S Keslar; C A de la Motte; A Valujskikh; R L Fairchild; W M Baldwin
Journal:  Am J Transplant       Date:  2015-01-12       Impact factor: 8.086

5.  Major effects of delayed graft function and cold ischaemia time on renal allograft survival.

Authors:  Isabel Quiroga; Philip McShane; Dicken D H Koo; Derek Gray; Peter J Friend; Susan Fuggle; Christopher Darby
Journal:  Nephrol Dial Transplant       Date:  2006-02-20       Impact factor: 5.992

6.  Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.

Authors:  G Einecke; B Sis; J Reeve; M Mengel; P M Campbell; L G Hidalgo; B Kaplan; P F Halloran
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

7.  Cold ischemia and the reduced long-term survival of cadaveric renal allografts.

Authors:  Abdulla K Salahudeen; Naeem Haider; Warren May
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

8.  Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients.

Authors:  Serena M Bagnasco; Andrea A Zachary; Lorraine C Racusen; Lois J Arend; Naima Carter-Monroe; Nada Alachkar; Susanna M Nazarian; Bonnie E Lonze; Robert A Montgomery; Edward S Kraus
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

9.  Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

Authors:  Grace W Wu; Jon A Kobashigawa; Michael C Fishbein; Jignesh K Patel; Michelle M Kittleson; Elaine F Reed; Krista K Kiyosaki; Abbas Ardehali
Journal:  J Heart Lung Transplant       Date:  2009-03-14       Impact factor: 10.247

10.  A reproducible mouse model of chronic allograft nephropathy with vasculopathy.

Authors:  Abolfazl Zarjou; Lingling Guo; Paul W Sanders; Roslyn B Mannon; Anupam Agarwal; James F George
Journal:  Kidney Int       Date:  2012-08-08       Impact factor: 10.612

View more
  4 in total

1.  Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function.

Authors:  Anil Dangi; Irma Husain; Collin Z Jordan; Shuangjin Yu; Naveen Natesh; Xiling Shen; Jean Kwun; Xunrong Luo
Journal:  J Am Soc Nephrol       Date:  2022-08-16       Impact factor: 14.978

2.  Molecular Signature of Antibody-Mediated Chronic Vasculopathy in Heart Allografts in a Novel Mouse Model.

Authors:  Hidetoshi Tsuda; Nina Dvorina; Karen S Keslar; Jessica Nevarez-Mejia; Nicole M Valenzuela; Elaine F Reed; Robert L Fairchild; William M Baldwin
Journal:  Am J Pathol       Date:  2022-04-29       Impact factor: 5.770

3.  B-cell Deficiency Attenuates Transplant Glomerulopathy in a Rat Model of Chronic Active Antibody-mediated Rejection.

Authors:  Shannon R Reese; Nancy A Wilson; Yabing Huang; Lucille Ptak; Kenna R Degner; Ding Xiang; Robert R Redfield; Weixiong Zhong; Sarah E Panzer
Journal:  Transplantation       Date:  2021-07-01       Impact factor: 5.385

4.  Balancing the View of C1q in Transplantation: Consideration of the Beneficial and Detrimental Aspects.

Authors:  Raneem Khedraki; Hirotsugu Noguchi; William M Baldwin
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.